{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T01:47:32Z","timestamp":1795225652863,"version":"4.10.3"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17H04085"],"award-info":[{"award-number":["JP17H04085"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H03499"],"award-info":[{"award-number":["JP20H03499"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["U1052"],"award-info":[{"award-number":["U1052"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0210036j0003"],"award-info":[{"award-number":["JP20fk0210036j0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0310101j1004"],"award-info":[{"award-number":["JP20fk0310101j1004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0310103j0204"],"award-info":[{"award-number":["JP20fk0310103j0204"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0310114j0004"],"award-info":[{"award-number":["JP20fk0310114j0004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20jm0210068j0002"],"award-info":[{"award-number":["JP20jm0210068j0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.antiviral.2020.104925","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T11:15:49Z","timestamp":1598613349000},"page":"104925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":389,"special_numbering":"C","title":["Hepatitis B virus biology and life cycle"],"prefix":"10.1016","volume":"182","author":[{"given":"Senko","family":"Tsukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Watashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104925_bib1","doi-asserted-by":"crossref","first-page":"25901","DOI":"10.1038\/srep25901","article-title":"The enzymes LSD1 and Set1A cooperate with the viral protein HBx to establish an active hepatitis B viral chromatin state","volume":"6","author":"Alarcon","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104925_bib2","doi-asserted-by":"crossref","first-page":"15958","DOI":"10.1074\/jbc.M116.724641","article-title":"RNA exosome complex regulates stability of the hepatitis B virus X-mRNA transcript in a non-stop-mediated (NSD) RNA quality control mechanism","volume":"291","author":"Aly","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104925_bib3","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1462-5822.2010.01557.x","article-title":"Alix regulates egress of hepatitis B virus naked capsid particles in an ESCRT-independent manner","volume":"13","author":"Bardens","year":"2011","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.antiviral.2020.104925_bib4","doi-asserted-by":"crossref","first-page":"9786","DOI":"10.1128\/JVI.79.15.9786-9798.2005","article-title":"Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition","volume":"79","author":"Barrera","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib5","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/j.1460-2075.1992.tb05420.x","article-title":"Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome","volume":"11","author":"Bartenschlager","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2020.104925_bib6","doi-asserted-by":"crossref","first-page":"36128","DOI":"10.1074\/jbc.M301069200","article-title":"Efficient Hsp90-independent in vitro activation by Hsc70 and Hsp40 of duck hepatitis B virus reverse transcriptase, an assumed Hsp90 client protein","volume":"278","author":"Beck","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104925_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI58847","article-title":"IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome","volume":"122","author":"Belloni","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2020.104925_bib8","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104925_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.1965.03080070025007","article-title":"A \"new\" antigen in leukemia sera","volume":"191","author":"Blumberg","year":"1965","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.antiviral.2020.104925_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/386088a0","article-title":"Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy","volume":"386","author":"Bottcher","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104925_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jhep.2016.05.014","article-title":"Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients","volume":"65","author":"Boyd","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104925_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.cr.7290187","article-title":"LRH-1\/hB1F and HNF1 synergistically up-regulate hepatitis B virus gene transcription and DNA replication","volume":"13","author":"Cai","year":"2003","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2020.104925_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/viro.1994.1627","article-title":"Regulation of hepatitis B virus ENI enhancer activity by hepatocyte-enriched transcription factor HNF3","volume":"205","author":"Chen","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104925_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005123","article-title":"The dual role of an ESCRT-0 component HGS in HBV transcription and naked capsid secretion","volume":"11","author":"Chou","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104925_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/386091a0","article-title":"Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy","volume":"386","author":"Conway","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104925_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128401","article-title":"Does tyrosyl DNA phosphodiesterase-2 play a role in hepatitis B virus genome repair?","volume":"10","author":"Cui","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104925_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(70)90926-8","article-title":"Virus-like particles in serum of patients with Australia-antigen-associated hepatitis","volume":"1","author":"Dane","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104925_bib18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsiere","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104925_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02203-18","article-title":"Peroxiredoxin 1, a novel HBx-interacting protein, interacts with exosome component 5 and negatively regulates hepatitis B virus (HBV) propagation through degradation of HBV RNA","volume":"93","author":"Deng","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib20","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.3389\/fmicb.2018.03257","article-title":"Troglitazone impedes the oligomerization of sodium taurocholate cotransporting polypeptide and entry of hepatitis B virus into hepatocytes","volume":"9","author":"Fukano","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104925_bib21","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/hep.29316","article-title":"Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis","volume":"66","author":"Gao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104925_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0092-8674(80)90443-2","article-title":"Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand","volume":"21","author":"Gerlich","year":"1980","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104925_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2005.03.090","article-title":"Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes","volume":"129","author":"Glebe","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104925_bib24","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/JVI.79.3.1613-1622.2005","article-title":"Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein","volume":"79","author":"Gripon","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib25","doi-asserted-by":"crossref","first-page":"10377","DOI":"10.1128\/JVI.73.12.10377-10386.1999","article-title":"In vivo regulation of hepatitis B virus replication by peroxisome proliferators","volume":"73","author":"Guidotti","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib26","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1128\/JVI.01123-07","article-title":"Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation","volume":"81","author":"Guo","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib27","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1128\/JVI.03094-14","article-title":"Inhibition of hepatitis B virus gene expression and replication by hepatocyte nuclear factor 6","volume":"89","author":"Hao","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib28","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/smll.201002020","article-title":"Single-particle tracking of hepatitis B virus-like vesicle entry into cells","volume":"7","author":"Hao","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.antiviral.2020.104925_bib29","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2013.06.020","article-title":"Identification of alpha-taxilin as an essential factor for the life cycle of hepatitis B virus","volume":"59","author":"Hoffmann","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104925_bib30","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/hep.29479","article-title":"Epigenetic regulation of hepatitis B virus covalently closed circular DNA: implications for epigenetic therapy against chronic hepatitis B","volume":"66","author":"Hong","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104925_bib31","doi-asserted-by":"crossref","first-page":"13122","DOI":"10.1128\/JVI.78.23.13122-13131.2004","article-title":"Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function","volume":"78","author":"Hu","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/v9030056","article-title":"Complete and incomplete hepatitis B virus particles: formation, function, and application","volume":"9","author":"Hu","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104925_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01032-19","article-title":"Revisiting hepatitis B virus: challenges of curative therapies","volume":"93","author":"Hu","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib34","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1073\/pnas.93.3.1060","article-title":"Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase","volume":"93","author":"Hu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104925_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/emboj\/16.1.59","article-title":"Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids","volume":"16","author":"Hu","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2020.104925_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/jvi.69.1.547-551.1995","article-title":"Retinoid X receptor alpha transactivates the hepatitis B virus enhancer 1 element by forming a heterodimeric complex with the peroxisome proliferator-activated receptor","volume":"69","author":"Huan","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib37","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1128\/JVI.00873-12","article-title":"Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis","volume":"86","author":"Huang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib38","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1073\/pnas.1808319115","article-title":"N6-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle","volume":"115","author":"Imam","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104925_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008338","article-title":"Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts","volume":"16","author":"Imam","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104925_bib40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0021-9258(17)49936-4","article-title":"The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network","volume":"295","author":"Iwamoto","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104925_bib41","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1073\/pnas.1811064116","article-title":"Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization","volume":"116","author":"Iwamoto","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104925_bib42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.febslet.2014.01.020","article-title":"Interaction between nucleophosmin and HBV core protein increases HBV capsid assembly","volume":"588","author":"Jeong","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2020.104925_bib43","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1128\/JVI.03109-15","article-title":"Subviral hepatitis B virus filaments, like infectious viral particles, are released via multivesicular bodies","volume":"90","author":"Jiang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib44","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1128\/JVI.07137-11","article-title":"In vitro epsilon RNA-dependent protein priming activity of human hepatitis B virus polymerase","volume":"86","author":"Jones","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1083\/jcb.145.1.45","article-title":"Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex","volume":"145","author":"Kann","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2020.104925_bib46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/hep.22359","article-title":"Requirement of the cyclic adenosine monophosphate response element-binding protein for hepatitis B virus replication","volume":"48","author":"Kim","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104925_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JVI.01232-09","article-title":"Incorporation of eukaryotic translation initiation factor eIF4E into viral nucleocapsids via interaction with hepatitis B virus polymerase","volume":"84","author":"Kim","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007124","article-title":"Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus","volume":"14","author":"Kitamura","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104925_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003361","article-title":"Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA","volume":"9","author":"Kitamura","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104925_bib50","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jhep.2018.08.012","article-title":"Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels","volume":"69","author":"Ko","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104925_bib51","doi-asserted-by":"crossref","first-page":"E4244","DOI":"10.1073\/pnas.1409986111","article-title":"Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses","volume":"111","author":"Koniger","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104925_bib52","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.1128\/JVI.00479-07","article-title":"Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin","volume":"81","author":"Lambert","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib53","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s12275-009-2720-z","article-title":"Hepatitis B virus core interacts with the host cell nucleolar protein, nucleophosmin 1","volume":"47","author":"Lee","year":"2009","journal-title":"J. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104925_bib54","first-page":"122","article-title":"Role of glycosaminoglycans for binding and infection of hepatitis B virus","volume":"10","author":"Leistner","year":"2008","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.antiviral.2020.104925_bib55","doi-asserted-by":"crossref","first-page":"68179","DOI":"10.18632\/oncotarget.11907","article-title":"Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo","volume":"7","author":"Leong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.antiviral.2020.104925_bib56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/viro.1995.0046","article-title":"HNF3 binds and activates the second enhancer, ENII, of hepatitis B virus","volume":"214","author":"Li","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104925_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004780","article-title":"TGF-beta suppression of HBV RNA through AID-dependent recruitment of an RNA exosome complex","volume":"11","author":"Liang","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104925_bib58","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1128\/JVI.02760-07","article-title":"Functional and structural dynamics of hepadnavirus reverse transcriptase during protein-primed initiation of reverse transcription: effects of metal ions","volume":"82","author":"Lin","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003613","article-title":"Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes","volume":"9","author":"Liu","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104925_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006296","article-title":"Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA","volume":"13","author":"Liu","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104925_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006784","article-title":"The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation","volume":"13","author":"Long","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104925_bib62","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0042-6822(91)91019-D","article-title":"Transcriptional factor C\/EBP binds to and transactivates the enhancer element II of the hepatitis B virus","volume":"183","author":"Lopez-Cabrera","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104925_bib63","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104925_bib64","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104925_bib65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3892\/ijmm.2012.1165","article-title":"Hepatitis B virus X protein modulates remodelling of minichromosomes related to hepatitis B virus replication in HepG2 cells","volume":"31","author":"Luo","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.antiviral.2020.104925_bib66","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1128\/JVI.00393-13","article-title":"Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment","volume":"87","author":"Macovei","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib67","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/JVI.01207-09","article-title":"Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells","volume":"84","author":"Macovei","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003494","article-title":"Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein","volume":"9","author":"Mao","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104925_bib69","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/jvi.45.1.165-172.1983","article-title":"Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virus","volume":"45","author":"Molnar-Kimber","year":"1983","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib70","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.30329","article-title":"PAPD5\/7 are host factors that are required for hepatitis B virus RNA stabilization","volume":"69","author":"Mueller","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104925_bib71","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2017.10.014","article-title":"A novel orally available small molecule that inhibits hepatitis B virus expression","volume":"68","author":"Mueller","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104925_bib72","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","article-title":"Hepatitis B virus X protein promotes degradation of SMC5\/6 to enhance HBV replication","volume":"16","author":"Murphy","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2020.104925_bib73","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1128\/jvi.70.5.2764-2773.1996","article-title":"A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis","volume":"70","author":"Nassal","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib74","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1128\/JVI.00465-08","article-title":"Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids","volume":"82","author":"Nguyen","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib75","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104925_bib76","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1423-0410.1968.tb04078.x","article-title":"Observations on Australia antigen in Japanese","volume":"15","author":"Okochi","year":"1968","journal-title":"Vox Sang."},{"key":"10.1016\/j.antiviral.2020.104925_bib77","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1006\/viro.1994.1574","article-title":"An NF1 motif plays a central role in hepatitis B virus enhancer","volume":"204","author":"Ori","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104925_bib78","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/viro.1995.1055","article-title":"Hepatitis B virus enhancer binds and is activated by the Hepatocyte nuclear factor 3","volume":"207","author":"Ori","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104925_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/genes10010007","article-title":"SMC5\/6: multifunctional player in replication","volume":"10","author":"Palecek","year":"2018","journal-title":"Genes"},{"key":"10.1016\/j.antiviral.2020.104925_bib80","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1462-5822.2009.01363.x","article-title":"Morphogenesis of hepatitis B virus and its subviral envelope particles","volume":"11","author":"Patient","year":"2009","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.antiviral.2020.104925_bib81","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1128\/JVI.02741-06","article-title":"Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking","volume":"81","author":"Patient","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib82","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1128\/jvi.68.9.5579-5587.1994","article-title":"Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis","volume":"68","author":"Pollack","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib83","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","article-title":"Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones","volume":"130","author":"Pollicino","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104925_bib84","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1515\/BC.1999.042","article-title":"Chaperones involved in hepatitis B virus morphogenesis","volume":"380","author":"Prange","year":"1999","journal-title":"Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104925_bib85","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1073\/pnas.60.3.814","article-title":"An antigen detected in the blood during the incubation period of serum hepatitis","volume":"60","author":"Prince","year":"1968","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104925_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005893","article-title":"DNA polymerase kappa is a key cellular factor for the formation of covalently closed circular DNA of hepatitis B virus","volume":"12","author":"Qi","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104925_bib87","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1099\/vir.0.006007-0","article-title":"Prospero-related homeobox protein (Prox1) inhibits hepatitis B virus replication through repressing multiple cis regulatory elements","volume":"90","author":"Qin","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib88","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1128\/JVI.02303-05","article-title":"Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection events","volume":"80","author":"Rabe","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib89","doi-asserted-by":"crossref","first-page":"9849","DOI":"10.1073\/pnas.1730940100","article-title":"Nuclear import of hepatitis B virus capsids and release of the viral genome","volume":"100","author":"Rabe","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104925_bib90","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jhep.2017.07.011","article-title":"How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach?","volume":"67","author":"Rajoriya","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104925_bib91","first-page":"1766","article-title":"Transcription of hepatitis B virus by RNA polymerase II","volume":"3","author":"Rall","year":"1983","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2020.104925_bib92","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00250-19","article-title":"Hepatitis B virus X protein function requires zinc binding","volume":"93","author":"Ramakrishnan","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib93","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/JVI.01562-12","article-title":"Independent activation of hepatitis B virus biosynthesis by retinoids, peroxisome proliferators, and bile acids","volume":"87","author":"Reese","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib94","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/hep.29912","article-title":"SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases","volume":"68","author":"Ren","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104925_bib95","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase","volume":"63","author":"Riviere","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104925_bib96","doi-asserted-by":"crossref","first-page":"104618","DOI":"10.1016\/j.antiviral.2019.104618","article-title":"Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5\/6","volume":"172","author":"Riviere","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104925_bib97","doi-asserted-by":"crossref","first-page":"32119","DOI":"10.1074\/jbc.M802632200","article-title":"gamma2-Adaptin, a ubiquitin-interacting adaptor, is a substrate to coupled ubiquitination by the ubiquitin ligase Nedd4 and functions in the endosomal pathway","volume":"283","author":"Rost","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104925_bib98","doi-asserted-by":"crossref","first-page":"29297","DOI":"10.1074\/jbc.M603517200","article-title":"Gamma-adaptin, a novel ubiquitin-interacting adaptor, and Nedd4 ubiquitin ligase control hepatitis B virus maturation","volume":"281","author":"Rost","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104925_bib99","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hep.21896","article-title":"Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans","volume":"46","author":"Schulze","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104925_bib100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcmgh.2018.10.010","article-title":"Inhibition of HBV transcription from cccDNA with nitazoxanide by targeting the HBx-DDB1 interaction","volume":"7","author":"Sekiba","year":"2019","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104925_bib101","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02230-18","article-title":"Cellular DNA topoisomerases are required for the synthesis of hepatitis B virus covalently closed circular DNA","volume":"93","author":"Sheraz","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib102","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.1128\/JVI.01196-07","article-title":"Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA binding","volume":"81","author":"Stahl","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091279","article-title":"Involvement of ESCRT-II in hepatitis B virus morphogenesis","volume":"9","author":"Stieler","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104925_bib104","doi-asserted-by":"crossref","first-page":"12874","DOI":"10.1038\/s41598-017-12497-y","article-title":"Involvement of PUF60 in transcriptional and post-transcriptional regulation of hepatitis B virus pregenomic RNA expression","volume":"7","author":"Sun","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104925_bib105","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1073\/pnas.98.4.1841","article-title":"Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism","volume":"98","author":"Tang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104925_bib106","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1128\/JVI.76.17.8572-8581.2002","article-title":"Mechanisms of inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by hepatocyte nuclear factor 3beta","volume":"76","author":"Tang","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007742","article-title":"DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA","volume":"15","author":"Tang","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104925_bib108","doi-asserted-by":"crossref","first-page":"E5715","DOI":"10.1073\/pnas.1518090112","article-title":"Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation","volume":"112","author":"Tropberger","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104925_bib109","first-page":"1","article-title":"Epigenetic and epitranscriptomic regulation of viral replication","author":"Tsai","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104925_bib110","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02007-17","article-title":"Hepatitis B virus DNA integration occurs early in the viral life cycle in an in vitro infection model via sodium taurocholate cotransporting polypeptide-dependent uptake of enveloped virus particles","volume":"92","author":"Tu","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib111","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1126\/science.1092066","article-title":"Inhibition of hepatitis B virus replication by APOBEC3G","volume":"303","author":"Turelli","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104925_bib112","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/(SICI)1097-0215(19960917)67:6<892::AID-IJC21>3.0.CO;2-2","article-title":"Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes","volume":"67","author":"Uchida","year":"1996","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.antiviral.2020.104925_bib113","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.28013","article-title":"A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses","volume":"63","author":"Verrier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104925_bib114","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0092-8674(92)90599-8","article-title":"The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis","volume":"71","author":"Wang","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104925_bib115","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1128\/jvi.67.11.6507-6512.1993","article-title":"Novel mechanism for reverse transcription in hepatitis B viruses","volume":"67","author":"Wang","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib116","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1128\/JVI.00011-09","article-title":"DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids","volume":"83","author":"Wang","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib117","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0923-2516(98)80085-X","article-title":"HNF1 is critical for the liver-specific function of HBV enhancer II","volume":"149","author":"Wang","year":"1998","journal-title":"Res. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib118","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1128\/JVI.76.12.5857-5865.2002","article-title":"Distinct requirement for two stages of protein-primed initiation of reverse transcription in hepadnaviruses","volume":"76","author":"Wang","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib119","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.1073\/pnas.0704000104","article-title":"Involvement of host cellular multivesicular body functions in hepatitis B virus budding","volume":"104","author":"Watanabe","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104925_bib120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-gamma and tumor necrosis factor-alpha produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104925_bib121","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.lfs.2018.12.057","article-title":"miRNA-548ah promotes the replication and expression of hepatitis B virus by targeting histone deacetylase 4","volume":"219","author":"Xing","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.antiviral.2020.104925_bib122","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.antiviral.2018.03.008","article-title":"Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic manners","volume":"153","author":"Xu","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104925_bib123","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jconrel.2011.11.004","article-title":"Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cells","volume":"160","author":"Yamada","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.antiviral.2020.104925_bib124","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.antiviral.2020.104925_bib125","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.7150\/thno.37173","article-title":"HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome","volume":"9","author":"Yang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.antiviral.2020.104925_bib126","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41426-018-0091-4","article-title":"RBM24 stabilizes hepatitis B virus pregenomic RNA but inhibits core protein translation by targeting the terminal redundancy sequence","volume":"7","author":"Yao","year":"2018","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2020.104925_bib127","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02161-18","article-title":"RNA-binding motif protein 24 (RBM24) is involved in pregenomic RNA packaging by mediating interaction between hepatitis B virus polymerase and the epsilon element","volume":"93","author":"Yao","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib128","first-page":"5044","article-title":"C\/EBP-like proteins binding to the functional box-alpha and box-beta of the second enhancer of hepatitis B virus","volume":"11","author":"Yuh","year":"1991","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2020.104925_bib129","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1006\/viro.1994.1359","article-title":"Differentiation-specific transcriptional regulation of the hepatitis B virus nucleocapsid gene in human hepatoma cell lines","volume":"202","author":"Zhang","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104925_bib130","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1128\/jvi.67.3.1472-1481.1993","article-title":"Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter","volume":"67","author":"Zhang","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104925_bib131","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/hep.29133","article-title":"PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation","volume":"66","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104925_bib132","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/hep.30497","article-title":"A functional variant in ubiquitin conjugating enzyme E2 L3 contributes to hepatitis B virus infection and maintains covalently closed circular DNA stability by inducing degradation of apolipoprotein B mRNA editing enzyme catalytic subunit 3A","volume":"69","author":"Zhou","year":"2019","journal-title":"Hepatology"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:35:35Z","timestamp":1759062935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220303399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":132,"alternative-id":["S0166354220303399"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104925","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B virus biology and life cycle","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104925"}}